Skip to content

MEDRAD® Mark 7 Arterion Injection System (REF ART 700 PEDL, ART 700 TABL, ART 700 OCS, ART 700 BASC, ART 700 VFL)Recalls & reported problems

Bayer Medical Care Inc. · MARK 7 ARTERION,PKGD,BASE SYSTEM,4th MC (86410095) · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00616258021362), received between Oct 11, 2023 and Dec 11, 2023 — classified as 2 injuries.

1 other recall cover devices cleared under the same FDA submission (K112086); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Cardiac Arrest1
  • Insufficient Information1
  • Low Blood Pressure/ Hypotension1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 11, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON NOVEMBER 15, 2023, BAYER MEDICAL CARE INC. RECEIVED INFORMATION THAT A PATIENT SUFFERED A CARDIAC ARREST WHILE CONNECTED TO A MEDRAD® MARK 7 ARTERION INJECTION SYSTEM (SERIAL NUMBER (B)(6). THE CUSTOMER REPORTED THAT THE INJECTOR FAILED TO RESPOND AFTER BEING ARMED. AS THE STAFF WERE ATTEMPTING TO TROUBLESHOOT THE INJECTOR ISSUE, THE PATIENT'S BLOOD PRESSURE DROPPED WHICH PROGRESSED TO CARDIAC ARREST. THE CUSTOMER REPORTED THAT, AFTER SUCCESSFUL RESUSCITATION, THE INJECTOR WAS RETURNED TO NORMAL OPERATION AND THE PROCEDURE WAS SUCCESSFULLY COMPLETED. THE CUSTOMER ALSO REPORTED THAT THE PATIENT HAS RECOVERED.

    Patient problems: Cardiac Arrest; Low Blood Pressure/ Hypotension

    MAUDE report 18303171 ↗
  • InjuryOct 11, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE CUSTOMER REPORTED THAT A PATIENT DEATH AND POTENTIAL BUT UNCONFIRMED AIR INJECTION OCCURRED WHILE A MEDRAD® MARK 7 ARTERION INJECTION SYSTEM (SERIAL NUMBER (B)(6)) WAS IN USE. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: Insufficient Information

    MAUDE report 17916338 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K112086. One submission often covers many models, so check the product and lot details in each record.

  • Z-0745-2019 · Dec 14, 2018 · Terminated
    MAVIG Portegra or Portegra2 Overhead Counterpoise System (OCS) used in conjunction with the Medrad Stellant CT Injection System (Certegra Workstation), Medrad Mark 7 Arterion" Inje

Other Injector And Syringe, Angiographic devices

All Injector And Syringe, Angiographic devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.